Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.10 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocytes; strongest in early spermatids | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 39 | 0.79 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 2729
Sealed predictions
- CNTNAP4 in dopamine neurons, braak+0.41 (p 0.272) → +0.19 (p 0.631)receipt 2737
- CNTNAP4 in oligodendrocytes, braak-0.01 (p 0.982) → -0.19 (p 0.619)receipt 2736
Swarm cases
receipt 2737: CNTNAP4 in dopamine neurons, braak
- power
- full sample +0.21 (p 0.403, n 18), 95% CI -0.28 to +0.62. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.21 (p 0.403, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.31 (p 0.214, n 18). could be the mix.
- skeptic
- leave-one-out range +0.11 to +0.33, sign flips 0; without severely affected donors +0.21 (p 0.403, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CNTNAP4 in dopamine neurons.
case closed: nothing better to follow up.
receipt 2736: CNTNAP4 in oligodendrocytes, braak
- power
- full sample +0.08 (p 0.754, n 18), 95% CI -0.40 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.854, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.16 (p 0.526, n 18). could be the mix.
- skeptic
- leave-one-out range -0.02 to +0.24, sign flips 3; without severely affected donors +0.08 (p 0.754, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CNTNAP4 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts